|
1
|
Wang G, Jacquet L, Karamariti E and Xu Q:
Origin and differentiation of vascular smooth muscle cells. J
Physiol. 593:3013–3030. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alexander MR and Owens GK: Epigenetic
control of smooth muscle cell differentiation and phenotypic
switching in vascular development and disease. Annu Rev Physiol.
74:13–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mellis D and Caporali A: MicroRNA
regulation of vascular function. Vasc Biol. 1:H41–H46. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang D and Atanasov AG: The microRNAs
regulating vascular smooth muscle cell proliferation: A minireview.
Int J Mol Sci. 20:3242019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Holland PW: Evolution of homeobox genes.
Wiley Interdiscip Rev Dev Biol. 2:31–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aspuria PJ, Cheon DJ, Gozo MC, Beach JA,
Recouvreux MS, Walts AE, Karlan BY and Orsulic S: HOXB13 controls
cell state through super-enhancers. Exp Cell Res. 393:1120392020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cantile M, Schiavo G, Terracciano L and
Cillo C: Homeobox genes in normal and abnormal vasculogenesis. Nutr
Metab Cardiovasc Dis. 18:651–658. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Attard G, Parker C, Eeles RA, Schröder F,
Tomlins SA, Tannock I, Drake CG and de Bono JS: Prostate cancer.
Lancet. 387:70–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li W, Deng P, Wang J, Li Z and Zhang H:
MiR-17 knockdown promotes vascular smooth muscle cell phenotypic
modulation through upregulated interferon regulator Factor 9
expression. Am J Hypertens. 33:1119–1126. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee MH, Kwon BJ, Koo MA, You KE and Park
JC: Mitogenesis of vascular smooth muscle cell stimulated by
platelet-derived growth factor-bb is inhibited by blocking of
intracellular signaling by epigallocatechin-3-O-gallate. Oxid Med
Cell Longev. 2013:8279052013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Risinger GM Jr, Hunt TS, Updike DL, Bullen
EC and Howard EW: Matrix metalloproteinase-2 expression by vascular
smooth muscle cells is mediated by both stimulatory and inhibitory
signals in response to growth factors. J Biol Chem.
281:25915–25925. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hsuan CF, Lu YC, Tsai IT, Houng JY, Wang
SW, Chang TH, Chen YL and Chang CC: Glossogyne tenuifolia
attenuates proliferation and migration of vascular smooth muscle
cells. Molecules. 25:58322020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xin H, Wang Z, Wu S, Wang P, Tao X, Xu C
and You L: Calcified decellularized arterial scaffolds impact
vascular smooth muscle cell transformation via downregulating α-SMA
expression and upregulating OPN expression. Exp Ther Med.
18:705–710. 2019.PubMed/NCBI
|
|
17
|
Je HD and Sohn UD: SM22alpha is required
for agonist-induced regulation of contractility: Evidence from
SM22alpha knockout mice. Mol Cells. 23:175–181. 2007.PubMed/NCBI
|
|
18
|
van Eys GJ, Niessen PM and Rensen SS:
Smoothelin in vascular smooth muscle cells. Trends Cardiovasc Med.
17:26–30. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Newby AC: Matrix metalloproteinases
regulate migration, proliferation, and death of vascular smooth
muscle cells by degrading matrix and non-matrix substrates.
Cardiovasc Res. 69:614–624. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dzau VJ, Braun-Dullaeus RC and Sedding DG:
Vascular proliferation and atherosclerosis: New perspectives and
therapeutic strategies. Nat Med. 8:1249–1256. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu F, Ahmed AS, Kang X, Hu G, Liu F, Zhang
W and Zhou J: MicroRNA-15b/16 attenuates vascular neointima
formation by promoting the contractile phenotype of vascular smooth
muscle through targeting YAP. Arterioscler Thromb Vasc Biol.
35:2145–2152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang F, Chen Q, He S, Yang M, Maguire EM,
An W, Afzal TA, Luong LA, Zhang L and Xiao Q: miR-22 Is a novel
mediator of vascular smooth muscle cell phenotypic modulation and
neointima formation. Circulation. 137:1824–1841. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Montezano AC, Lopes RA, Neves KB, Rios F
and Touyz RM: Isolation and culture of vascular smooth muscle cells
from small and large vessels. Methods Mol Biol. 1527:349–354. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li P, Zhu N, Yi B, Wang N, Chen M, You X,
Zhao X, Solomides CC, Qin Y and Sun J: MicroRNA-663 regulates human
vascular smooth muscle cell phenotypic switch and vascular
neointimal formation. Circ Res. 113:1117–1127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ohnaka M, Marui A, Yamahara K, Minakata K,
Yamazaki K, Kumagai M, Masumoto H, Tanaka S, Ikeda T and Sakata R:
Effect of microRNA-145 to prevent vein graft disease in rabbits by
regulation of smooth muscle cell phenotype. J Thorac Cardiovasc
Surg. 148:676–682.e2. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cordes KR, Sheehy NT, White MP, Berry EC,
Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D:
miR-145 and miR-143 regulate smooth muscle cell fate and
plasticity. Nature. 460:705–710. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vengrenyuk Y, Nishi H, Long X, Ouimet M,
Savji N, Martinez FO, Cassella CP, Moore KJ, Ramsey SA, Miano JM
and Fisher EA: Cholesterol loading reprograms the
microRNA-143/145-myocardin axis to convert aortic smooth muscle
cells to a dysfunctional macrophage-like phenotype. Arterioscler
Thromb Vasc Biol. 35:535–546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang D, Sun C, Zhang J, Lin S, Zhao L,
Wang L, Lin R, Lv J and Xin S: Proliferation of vascular smooth
muscle cells under inflammation is regulated by NF-κB
p65/microRNA-17/RB pathway activation. Int J Mol Med. 41:43–50.
2018.PubMed/NCBI
|
|
29
|
Leeper NJ, Raiesdana A, Kojima Y, Chun HJ,
Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS and Spin
JM: MicroRNA-26a is a novel regulator of vascular smooth muscle
cell function. J Cell Physiol. 226:1035–1043. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tan J, Yang L, Liu C and Yan Z:
MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell
proliferation and vein graft neointimal hyperplasia. Sci Rep.
7:466022017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen Z, Wu J, Yang C, Fan P, Balazs L,
Jiao Y, Lu M, Gu W, Li C, Pfeffer LM, et al: DiGeorge syndrome
critical region 8 (DGCR8) protein-mediated microRNA biogenesis is
essential for vascular smooth muscle cell development in mice. J
Biol Chem. 287:19018–19028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen T, Zhou Q, Tang H, Bozkanat M, Yuan
JX, Raj JU and Zhou G: miR-17/20 Controls prolyl hydroxylase 2
(PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to regulate pulmonary
artery smooth muscle cell proliferation. J Am Heart Assoc.
5:e0045102016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang X, Sun Y, Xu T, Qian K, Huang B,
Zhang K, Song Z, Qian T, Shi J and Li L: HOXB13 promotes
proliferation, migration, and invasion of glioblastoma through
transcriptional upregulation of lncRNA HOXC-AS3. J Cell Biochem.
120:15527–15537. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ewing CM, Ray AM, Lange EM, Zuhlke KA,
Robbins CM, Tembe WD, Wiley KE, Isaacs SD, Johng D, Wang Y, et al:
Germline mutations in HOXB13 and prostate-cancer risk. N Engl J
Med. 366:141–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nguyen NUN, Canseco DC, Xiao F, Nakada Y,
Li S, Lam NT, Muralidhar SA, Savla JJ, Hill JA, Le V, et al: A
calcineurin-Hoxb13 axis regulates growth mode of mammalian
cardiomyocytes. Nature. 582:271–276. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zuo L, Tan T, Wei C, Wang H, Tan L, Hao Y,
Qian J, Chen Y and Wu C: HOXB13 expression is correlated with
hepatic inflammatory activity of patients with hepatic fibrosis. J
Mol Histol. 51:183–189. 2020. View Article : Google Scholar : PubMed/NCBI
|
